183
Participants
Start Date
February 21, 2022
Primary Completion Date
March 31, 2026
Study Completion Date
April 30, 2027
Setrusumab
A fully human sclerostin neutralizing monoclonal antibody (mAb) administered once a month (QM) via intravenous (IV) infusion
Placebo
A 5% dextrose/glucose solution administered QM via IV infusion
The Children's Hospital of Philadelphia, Philadelphia
Nemours/ Alfred i. duPoint Hospital for Children, Wilmington
Children's National Medical Center, Washington D.C.
Kennedy Krieger Institute, Baltimore
Atrium Health Levine Children's Hospital, Charlotte
University of South Florida, Tampa
Vanderbilt University Medical Center, Nashville
Otto von Guericke University Magdeburg, Magdeburg
Nationwide Children's Hospital- Ohio State University College of Medicine, Columbus
Indiana University Hospital, Indianapolis
UW Health University Hospital, Madison
Shriners Hospitals for Children - Chicago, Chicago
Washington University School of Medicine, St Louis
Children's Hospital and Medical Center, Omaha
Arkansas Children's Hospital, Little Rock
Cook Children's Medical Center, Fort Worth
Baylor College of Medicine, Houston
Children's Hospital Colorado, Aurora
New Mexico Clinical Research & Osteoporosis Center, Inc., Albuquerque
Children's Hospital Los Angeles, Los Angeles
Shriners Hospital for Children - Northern California, Sacramento
Musculoskeletal Center Würzburg, Würzburg
Connecticut Children's Medical Center, Hartford
Yale New Haven Hospital, New Haven
Boston Children's Hospital, Boston
Queensland Paediatric Endocrinology, South Brisbane
Royal Children's Hospital, Melbourne
London Health Sciences Center, London
University of Toronto- The Hospital for Sick Children (SickKids), Toronto
Institut Imagine, Paris
University of Cologne, Cologne
Istituto Ortopedico Rizzoli, Bologna
Universita Degli Studi Di Verona, Verona
Wilhelmina Children's Hospital, Utrecht
Uniwersytet Medyczny w Lodzi - Klinika Endokrynologii i Chorob Metabolicznych, Lodz
Gazi University, Ankara
Marmara University, Istanbul
Royal Manchester Childrens Hospital, Manchester
Children's Hospital of Eastern Ontario, Ottawa
McGill University Health Centre, Montreal
Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome
Hospital de Santa Maria, Lisbon
Centro Hospitalar do Porto, Porto
Sheffield Children's NHS Foundation Trust, Sheffield
Collaborators (1)
Mereo BioPharma
INDUSTRY
Ultragenyx Pharmaceutical Inc
INDUSTRY